| Ytd | 0.67% | |
| 1y | -17.14% |
| Open | 276.74 | Prev Close | 275.68 | Low | 273.66 | High | 279.53 | Mkt Cap | 73.29B |
| Vol | 1.77M | Avg Vol | 1.61M | EPS | 23.58 | P/E | 11.75 | Forward P/E | 8.28 |
| Beta | 0.30 | Short Ratio | 4.73 | Inst. Own | 92.75% | Dividend | 6.24 | Div Yield | 2.26 |
| Ex Div Date | 06-04 | Earning | 07-30 | 50-d Avg | 284.54 | 200-d Avg | 280.50 | 1yr Est | 340.50 |
New program introduces AI-enabled capabilities to personalize support, streamline prescription proce
CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to
New "Courage in Service" grant builds on company's long-standing support for military and veteran co
The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced $3
Mizuho analyst Ann Hynes maintains Cigna Group (NYSE:CI) with a Outperform and raises the price t
https://www.reuters.com/world/cigna-drops-coverage-glp-1-obesity-drugs-its-own-employees-2026-06-02/
Barclays analyst Andrew Mok downgrades Cigna Group (NYSE:CI) from Overweight to Equal-Weight and
Morgan Stanley analyst Erin Wright maintains Cigna Group (NYSE:CI) with a Overweight and raises t
Top Wall Street analysts changed outlook on top names. For all changes, see analyst ratings page. An
Deutsche Bank analyst George Hill downgrades Cigna Group (NYSE:CI) from Buy to Hold and lowers th
Bernstein analyst Lance Wilkes maintains Cigna Group (NYSE:CI) with a Outperform and raises the p
Guggenheim analyst Jason Cassorla maintains Cigna Group (NYSE:CI) with a Buy and raises the price
RBC Capital analyst Ben Hendrix maintains Cigna Group (NYSE:CI) with a Outperform and raises the
Cantor Fitzgerald analyst Sarah James maintains Cigna Group (NYSE:CI) with a Overweight and raise
Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and raises the pric
Wells Fargo analyst Stephen Baxter maintains Cigna Group (NYSE:CI) with a Equal-Weight and raises
Cigna beats Q1 estimates on Evernorth growth, raises outlook, but reports a dip in customer relation
Cigna Group (NYSE:CI) reported quarterly earnings of $7.79 per share which beat the analyst consensu
Jefferies analyst David Windley maintains Cigna Group (NYSE:CI) with a Buy and lowers the price t
https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-payment-pol
Healthcare tops Americans' concerns again, with rising costs forcing millions to cut spending, d
Mark Cuban calls $30K corporate healthcare costs 'insane,' backing a new bill to break up bi
Bernstein analyst Lance Wilkes upgrades Cigna Group (NYSE:CI) from Market Perform to Outperform a
Piper Sandler analyst Jessica Tassan reiterates Cigna Group (NYSE:CI) with a Overweight and lower
The Cigna Group (NYSE:CI) shares are trading lower Tuesday after the company announced that David Co
The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive offi
https://www.statnews.com/2026/02/26/cigna-carepathrx-acquisition-vertical-integration/?utm_campaign=
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le
Trump's Medicare rate cap and a new "radical" PBM transparency rule hit UnitedHealth, CV
Here's a look at this week's earnings calendar, featuring over 100 S&P 500 members.
Trump's flat Medicare Advantage proposal shocks investors, risking a 20% earnings hit and delayi
https://www.wsj.com/health/healthcare/trump-administration-proposes-keeping-steady-the-rates-medicar
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm thes
Low-volatility ETFs are in focus as JPMorgan warns of overcrowding in speculative AI and growth stoc
BofA outlines risks and upside for managed care stocks, favoring Cigna and Alignment while flagging
Mark Cuban slammed major insurers for mistreating independent doctors and argued that the Affordable
Trump prepares a health care plan proposing an ACA subsidy extension, new eligibility caps and measu
https://www.politico.com/newsletters/inside-congress/2025/11/24/trumps-obamacare-move-blindsides-con
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as invest
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and e
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, dela